CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 25 enrolled
Drug / intervention
Altreno +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04548349
NCT04548349Phase 4Completed
CompareCT.gov

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

Beth Israel Deaconess Medical Center·interventional·Posted Sep 14, 2020·Updated Feb 6, 2024

In Brief

A Phase 4 clinical trial evaluating Altreno and Benzoyl peroxide for Acne and Healthy. Completed, enrolled 25 participants across 1 site.

Detailed Summary

The study objective is to characterize the shift in the diversity and abundance of the skin microbial community at baseline and in response to Altreno monotherapy as compared to benzoyl peroxide (BPO) 2.5% leave-on gel monotherapy in acne patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne, Healthy
CountriesUnited States
CollaboratorsOrtho Dermatologics

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedSep 14, 2020
Enrollment StartApr 23, 2021
Primary CompletionAug 22, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.8 years ago

Interventions

Altrenodrug

Acne patients will be assigned to Altreno once daily.

Benzoyl peroxidedrug

Acne patients will be assigned to BPO leave-on gel once daily.